Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephanie Lee
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Stanford University Hospitals and Clinics
Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 Dec 2014
- Completion
- 31 Dec 2015
- Last update posted
- 15 Jun 2016
- Registered enrollment
- 72
- Registry id
- NCT01309997
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.